Glassman Wealth Services’s Globus Medical GMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-20
Closed -$1.07K 842
2023
Q4
$1.07K Buy
20
+8
+67% +$390 ﹤0.01% 1523
2023
Q3
$596 Buy
+12
New +$671 ﹤0.01% 1699
2023
Q2
Sell
-13
Closed -$736 1957
2023
Q1
$736 Sell
13
-96
-88% -$6.16K ﹤0.01% 1530
2022
Q4
$8.1K Hold
109
﹤0.01% 890
2022
Q3
$6K Hold
109
﹤0.01% 940
2022
Q2
$6K Buy
+109
New +$7.17K ﹤0.01% 947

Other funds holding GMED

Glassman Wealth Services's GMED Position: Q1 2024 in Review

Glassman Wealth Services sold out of Globus Medical (GMED) in Q1 2024, closing a stake of 20 shares — an estimated $1.07K sold.

Glassman Wealth Services first reported a position in GMED in Q2 2022 and held it in 6 quarters. The position peaked at $8.1K in Q4 2022. 439 funds tracked by Wall St. Rank hold GMED as of Q1 2024.

  • Glassman Wealth Services reported no remaining Globus Medical position as of Q1 2024 after selling out during the quarter.
  • Glassman Wealth Services sold 20 Globus Medical shares in Q1 2024, an estimated $1.07K.
  • Glassman Wealth Services first reported a position in Globus Medical in Q2 2022 and held it in 6 quarters.
  • Glassman Wealth Services's Globus Medical position peaked at $8.1K in Q4 2022.
  • 439 funds tracked by Wall St. Rank held Globus Medical as of Q1 2024.

Based on Glassman Wealth Services's 13F filing for Q1 2024, filed 3 May 2024.